Trial · NCT01392300
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Main Period (MP) | STARTED | Double-blind IncobotulinumtoxinA (Xeomin) (400 Units) | 210 | |
| Main Period (MP) | STARTED | Double-blind Placebo Comparator | 107 | |
| Main Period (MP) | STARTED | OLEX IncobotulinumtoxinA (Xeomin) (400 Units, 3 Injections) | 0 | |
| Main Period (MP) | COMPLETED | Double-blind IncobotulinumtoxinA (Xeomin) (400 Units) | 199 | |
| Main Period (MP) | COMPLETED | Double-blind Placebo Comparator | 100 | |
| Main Period (MP) | COMPLETED | OLEX IncobotulinumtoxinA (Xeomin) (400 Units, 3 Injections) | 0 | |
| Main Period (MP) | NOT COMPLETED | Double-blind IncobotulinumtoxinA (Xeomin) (400 Units) | 11 | |
| Main Period (MP) | NOT COMPLETED | Double-blind Placebo Comparator | 7 | |
| Main Period (MP) | NOT COMPLETED | OLEX IncobotulinumtoxinA (Xeomin) (400 Units, 3 Injections) | 0 | |
| Open Label Extension (OLEX) Period | STARTED | Double-blind IncobotulinumtoxinA (Xeomin) (400 Units) | 0 | |
| Open Label Extension (OLEX) Period | STARTED | Double-blind Placebo Comparator | 0 | |
| Open Label Extension (OLEX) Period | STARTED | OLEX IncobotulinumtoxinA (Xeomin) (400 Units, 3 Injections) | 299 | |
| Open Label Extension (OLEX) Period | COMPLETED | Double-blind IncobotulinumtoxinA (Xeomin) (400 Units) | 0 | |
| Open Label Extension (OLEX) Period | COMPLETED | Double-blind Placebo Comparator | 0 | |
| Open Label Extension (OLEX) Period | COMPLETED | OLEX IncobotulinumtoxinA (Xeomin) (400 Units, 3 Injections) | 248 | |
| Open Label Extension (OLEX) Period | NOT COMPLETED | Double-blind IncobotulinumtoxinA (Xeomin) (400 Units) | 0 | |
| Open Label Extension (OLEX) Period | NOT COMPLETED | Double-blind Placebo Comparator | 0 | |
| Open Label Extension (OLEX) Period | NOT COMPLETED | OLEX IncobotulinumtoxinA (Xeomin) (400 Units, 3 Injections) | 51 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01392300/flow